Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 136 Pages
Report ld: 4895506
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Isolated Lung Perfusion System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
From a downstream perspective, Drug Testing accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Isolated Lung Perfusion System leading manufacturers including Harvard Apparatus, Transmedics, Bridge to Life, Radnoti, ALCOTT BIOTECH, XVIVO, etc., dominate supply; the top five capture approximately % of global revenue, with Harvard Apparatus leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Isolated Lung Perfusion System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Harvard Apparatus
- Transmedics
- Bridge to Life
- Radnoti
- ALCOTT BIOTECH
- XVIVO
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Animal Isolated Lung Perfusion System
- Human Isolated Lung Perfusion System
Segment by Application
- Drug Testing
- Toxicology Testing
- Lung Transplant
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Isolated Lung Perfusion System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Isolated Lung Perfusion System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Isolated Lung Perfusion System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Animal Isolated Lung Perfusion System
1.2.3 Human Isolated Lung Perfusion System
1.3 Market Segmentation by Application
1.3.1 Global Isolated Lung Perfusion System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Testing
1.3.3 Toxicology Testing
1.3.4 Lung Transplant
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Isolated Lung Perfusion System Revenue Estimates and Forecasts 2020-2031
2.2 Global Isolated Lung Perfusion System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Isolated Lung Perfusion System Sales Estimates and Forecasts 2020-2031
2.4 Global Isolated Lung Perfusion System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Isolated Lung Perfusion System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Isolated Lung Perfusion System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Animal Isolated Lung Perfusion System Market Size by Manufacturers
3.5.2 Human Isolated Lung Perfusion System Market Size by Manufacturers
3.6 Global Isolated Lung Perfusion System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Isolated Lung Perfusion System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Isolated Lung Perfusion System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Isolated Lung Perfusion System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Isolated Lung Perfusion System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
6.4 North America Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Isolated Lung Perfusion System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
7.4 Europe Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Isolated Lung Perfusion System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Isolated Lung Perfusion System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Isolated Lung Perfusion System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Isolated Lung Perfusion System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Harvard Apparatus
11.1.1 Harvard Apparatus Corporation Information
11.1.2 Harvard Apparatus Business Overview
11.1.3 Harvard Apparatus Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.1.4 Harvard Apparatus Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Harvard Apparatus Isolated Lung Perfusion System Sales by Product in 2024
11.1.6 Harvard Apparatus Isolated Lung Perfusion System Sales by Application in 2024
11.1.7 Harvard Apparatus Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.1.8 Harvard Apparatus Isolated Lung Perfusion System SWOT Analysis
11.1.9 Harvard Apparatus Recent Developments
11.2 Transmedics
11.2.1 Transmedics Corporation Information
11.2.2 Transmedics Business Overview
11.2.3 Transmedics Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.2.4 Transmedics Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Transmedics Isolated Lung Perfusion System Sales by Product in 2024
11.2.6 Transmedics Isolated Lung Perfusion System Sales by Application in 2024
11.2.7 Transmedics Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.2.8 Transmedics Isolated Lung Perfusion System SWOT Analysis
11.2.9 Transmedics Recent Developments
11.3 Bridge to Life
11.3.1 Bridge to Life Corporation Information
11.3.2 Bridge to Life Business Overview
11.3.3 Bridge to Life Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.3.4 Bridge to Life Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bridge to Life Isolated Lung Perfusion System Sales by Product in 2024
11.3.6 Bridge to Life Isolated Lung Perfusion System Sales by Application in 2024
11.3.7 Bridge to Life Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.3.8 Bridge to Life Isolated Lung Perfusion System SWOT Analysis
11.3.9 Bridge to Life Recent Developments
11.4 Radnoti
11.4.1 Radnoti Corporation Information
11.4.2 Radnoti Business Overview
11.4.3 Radnoti Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.4.4 Radnoti Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Radnoti Isolated Lung Perfusion System Sales by Product in 2024
11.4.6 Radnoti Isolated Lung Perfusion System Sales by Application in 2024
11.4.7 Radnoti Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.4.8 Radnoti Isolated Lung Perfusion System SWOT Analysis
11.4.9 Radnoti Recent Developments
11.5 ALCOTT BIOTECH
11.5.1 ALCOTT BIOTECH Corporation Information
11.5.2 ALCOTT BIOTECH Business Overview
11.5.3 ALCOTT BIOTECH Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.5.4 ALCOTT BIOTECH Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Product in 2024
11.5.6 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Application in 2024
11.5.7 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.5.8 ALCOTT BIOTECH Isolated Lung Perfusion System SWOT Analysis
11.5.9 ALCOTT BIOTECH Recent Developments
11.6 XVIVO
11.6.1 XVIVO Corporation Information
11.6.2 XVIVO Business Overview
11.6.3 XVIVO Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.6.4 XVIVO Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 XVIVO Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Isolated Lung Perfusion System Industry Chain
12.2 Isolated Lung Perfusion System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Isolated Lung Perfusion System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Isolated Lung Perfusion System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Isolated Lung Perfusion System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Isolated Lung Perfusion System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Isolated Lung Perfusion System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Isolated Lung Perfusion System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Isolated Lung Perfusion System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Isolated Lung Perfusion System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Isolated Lung Perfusion System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Isolated Lung Perfusion System Sales by Region (2020-2025) & (Units)
Table 8. Global Isolated Lung Perfusion System Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Isolated Lung Perfusion System Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Isolated Lung Perfusion System Sales Share by Manufacturers (2020-2025)
Table 12. Global Isolated Lung Perfusion System Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Isolated Lung Perfusion System Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Isolated Lung Perfusion System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isolated Lung Perfusion System as of 2024)
Table 16. Global Isolated Lung Perfusion System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Isolated Lung Perfusion System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Isolated Lung Perfusion System Manufacturing Base and Headquarters
Table 19. Global Isolated Lung Perfusion System Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Isolated Lung Perfusion System Sales by Type (2020-2025) & (Units)
Table 23. Global Isolated Lung Perfusion System Sales by Type (2026-2031) & (Units)
Table 24. Global Isolated Lung Perfusion System Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Isolated Lung Perfusion System Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Isolated Lung Perfusion System ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Isolated Lung Perfusion System Sales by Application (2020-2025) & (Units)
Table 29. Global Isolated Lung Perfusion System Sales by Application (2026-2031) & (Units)
Table 30. Isolated Lung Perfusion System High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Isolated Lung Perfusion System Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Isolated Lung Perfusion System Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Isolated Lung Perfusion System ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Isolated Lung Perfusion System Growth Accelerators and Market Barriers
Table 37. North America Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Isolated Lung Perfusion System Growth Accelerators and Market Barriers
Table 40. Europe Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Isolated Lung Perfusion System Growth Accelerators and Market Barriers
Table 45. Southeast Asia Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Isolated Lung Perfusion System Investment Opportunities and Key Challenges
Table 47. Central and South America Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Isolated Lung Perfusion System Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Harvard Apparatus Corporation Information
Table 51. Harvard Apparatus Description and Major Businesses
Table 52. Harvard Apparatus Product Models, Descriptions and Specifications
Table 53. Harvard Apparatus Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Harvard Apparatus Sales Value Proportion by Product in 2024
Table 55. Harvard Apparatus Sales Value Proportion by Application in 2024
Table 56. Harvard Apparatus Sales Value Proportion by Geographic Area in 2024
Table 57. Harvard Apparatus Isolated Lung Perfusion System SWOT Analysis
Table 58. Harvard Apparatus Recent Developments
Table 59. Transmedics Corporation Information
Table 60. Transmedics Description and Major Businesses
Table 61. Transmedics Product Models, Descriptions and Specifications
Table 62. Transmedics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Transmedics Sales Value Proportion by Product in 2024
Table 64. Transmedics Sales Value Proportion by Application in 2024
Table 65. Transmedics Sales Value Proportion by Geographic Area in 2024
Table 66. Transmedics Isolated Lung Perfusion System SWOT Analysis
Table 67. Transmedics Recent Developments
Table 68. Bridge to Life Corporation Information
Table 69. Bridge to Life Description and Major Businesses
Table 70. Bridge to Life Product Models, Descriptions and Specifications
Table 71. Bridge to Life Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Bridge to Life Sales Value Proportion by Product in 2024
Table 73. Bridge to Life Sales Value Proportion by Application in 2024
Table 74. Bridge to Life Sales Value Proportion by Geographic Area in 2024
Table 75. Bridge to Life Isolated Lung Perfusion System SWOT Analysis
Table 76. Bridge to Life Recent Developments
Table 77. Radnoti Corporation Information
Table 78. Radnoti Description and Major Businesses
Table 79. Radnoti Product Models, Descriptions and Specifications
Table 80. Radnoti Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Radnoti Sales Value Proportion by Product in 2024
Table 82. Radnoti Sales Value Proportion by Application in 2024
Table 83. Radnoti Sales Value Proportion by Geographic Area in 2024
Table 84. Radnoti Isolated Lung Perfusion System SWOT Analysis
Table 85. Radnoti Recent Developments
Table 86. ALCOTT BIOTECH Corporation Information
Table 87. ALCOTT BIOTECH Description and Major Businesses
Table 88. ALCOTT BIOTECH Product Models, Descriptions and Specifications
Table 89. ALCOTT BIOTECH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. ALCOTT BIOTECH Sales Value Proportion by Product in 2024
Table 91. ALCOTT BIOTECH Sales Value Proportion by Application in 2024
Table 92. ALCOTT BIOTECH Sales Value Proportion by Geographic Area in 2024
Table 93. ALCOTT BIOTECH Isolated Lung Perfusion System SWOT Analysis
Table 94. ALCOTT BIOTECH Recent Developments
Table 95. XVIVO Corporation Information
Table 96. XVIVO Description and Major Businesses
Table 97. XVIVO Product Models, Descriptions and Specifications
Table 98. XVIVO Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. XVIVO Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Isolated Lung Perfusion System Product Picture
Figure 2. Global Isolated Lung Perfusion System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Animal Isolated Lung Perfusion System Product Picture
Figure 4. Human Isolated Lung Perfusion System Product Picture
Figure 5. Global Isolated Lung Perfusion System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Drug Testing
Figure 7. Toxicology Testing
Figure 8. Lung Transplant
Figure 9. Others
Figure 10. Isolated Lung Perfusion System Report Years Considered
Figure 11. Global Isolated Lung Perfusion System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 13. Global Isolated Lung Perfusion System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Isolated Lung Perfusion System Revenue Market Share by Region (2020-2031)
Figure 15. Global Isolated Lung Perfusion System Sales (2020-2031) & (Units)
Figure 16. Global Isolated Lung Perfusion System Sales (CAGR) by Region (2020-2031) (Units)
Figure 17. Global Isolated Lung Perfusion System Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Isolated Lung Perfusion System Sales Volume Market Share in 2024
Figure 19. Global Isolated Lung Perfusion System Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Animal Isolated Lung Perfusion System Revenue Market Share by Manufacturer in 2024
Figure 22. Human Isolated Lung Perfusion System Revenue Market Share by Manufacturer in 2024
Figure 23. Global Isolated Lung Perfusion System Sales Market Share by Type (2020-2031)
Figure 24. Global Isolated Lung Perfusion System Revenue Market Share by Type (2020-2031)
Figure 25. Global Isolated Lung Perfusion System Sales Market Share by Application (2020-2031)
Figure 26. Global Isolated Lung Perfusion System Revenue Market Share by Application (2020-2031)
Figure 27. North America Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
Figure 28. North America Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
Figure 30. North America Isolated Lung Perfusion System Sales Volume (Units) by Type (2020- 2031)
Figure 31. North America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
Figure 33. North America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
Figure 38. Europe Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
Figure 40. Europe Isolated Lung Perfusion System Sales Volume (Units) by Type (2020-2031)
Figure 41. Europe Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
Figure 43. Europe Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 45. France Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
Figure 50. Asia-Pacific Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Isolated Lung Perfusion System Sales Volume (Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
Figure 55. Asia-Pacific Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 60. India Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
Figure 62. Central and South America Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Isolated Lung Perfusion System Sales Volume (Units) by Type (2021-2031)
Figure 65. Central and South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
Figure 67. Central and South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
Figure 71. Middle East and Africa Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Isolated Lung Perfusion System Sales Volume (Units) by Type (2021-2031)
Figure 74. South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
Figure 76. Middle East and Africa Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
Figure 81. Isolated Lung Perfusion System Industry Chain Mapping
Figure 82. Regional Isolated Lung Perfusion System Manufacturing Base Distribution (%)
Figure 83. Global Isolated Lung Perfusion System Production Market Share by Region (2020-2031)
Figure 84. Isolated Lung Perfusion System Production Process
Figure 85. Regional Isolated Lung Perfusion System Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Isolated Lung Perfusion System market?
The top companies in the global Isolated Lung Perfusion System market are Harvard Apparatus、Transmedics、Bridge to Life.
Related Reports
Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Isolated Lung Perfusion System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 141
USD 4900.00
(Single User License)
Global Isolated Lung Perfusion System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isolated Lung Perfusion System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 78
USD 4250.00
(Single User License)
Isolated Lung Perfusion System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isolated Lung Perfusion System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 108
USD 3950.00
(Single User License)
Global Isolated Lung Perfusion System Market Research Report 2026
The global Isolated Lung Perfusion System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 114
USD 2900.00
(Single User License)
Global Isolated Lung Perfusion System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Isolated Lung Perfusion System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
Isolated Lung Perfusion System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isolated Lung Perfusion System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 108
USD 3950.00
(Single User License)
Global Isolated Lung Perfusion System Market Research Report 2025
The global market for Isolated Lung Perfusion System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 81
USD 2900.00
(Single User License)
Global and United States Isolated Lung Perfusion System Market Report & Forecast 2024-2030
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published Date: 2024-05-27
Pages: 116
USD 4350.00
(Single User License)
Global Isolated Lung Perfusion System Market Research Report 2024
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published Date: 2024-05-27
Pages: 85
USD 2900.00
(Single User License)
Global Isolated Lung Perfusion System Market Insights, Forecast to 2030
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published Date: 2024-05-27
Pages: 136
USD 4900.00
(Single User License)
Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Isolated Lung Perfusion System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 141
USD 4900.00 (Single User License)Global Isolated Lung Perfusion System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Isolated Lung Perfusion System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 78
USD 4250.00 (Single User License)Isolated Lung Perfusion System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Isolated Lung Perfusion System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 108
USD 3950.00 (Single User License)Global Isolated Lung Perfusion System Market Research Report 2026
The global Isolated Lung Perfusion System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 114
USD 2900.00 (Single User License)Global Isolated Lung Perfusion System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Isolated Lung Perfusion System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
USD 4250.00 (Single User License)Isolated Lung Perfusion System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Isolated Lung Perfusion System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 108
USD 3950.00 (Single User License)Global Isolated Lung Perfusion System Market Research Report 2025
The global market for Isolated Lung Perfusion System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 81
USD 2900.00 (Single User License)Global and United States Isolated Lung Perfusion System Market Report & Forecast 2024-2030
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published: 2024-05-27
Pages: 116
USD 4350.00 (Single User License)Global Isolated Lung Perfusion System Market Research Report 2024
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published: 2024-05-27
Pages: 85
USD 2900.00 (Single User License)Global Isolated Lung Perfusion System Market Insights, Forecast to 2030
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
Published: 2024-05-27
Pages: 136
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now